Description
Sonic Healthcare Ltd. engages in the provision of medical diagnostics services. It operates through the following segments: Laboratory, Radiology, and Other. The Laboratory segment offers pathology and clinical services in Australia, New Zealand, the United Kingdom, the United States of America, Germany, Switzerland, Belgium, and Ireland. The Radiology segment includes diagnostic imaging services in Australia. The Other segment covers the corporate office function, medical center operations and occupation health services, and other minor operations. The company was founded on September 25, 1934 and is headquartered in Sydney, Australia.
Sonic Healthcare Ltd. engages in the provision of medical diagnostics services. It operates through the following segments: Laboratory, Radiology, and Other. The Laboratory segment offers pathology and clinical services in Australia, New Zealand, the United Kingdom, the United States of America, Germany, Switzerland, Belgium, and Ireland. The Radiology segment includes diagnostic imaging services in Australia. The Other segment covers the corporate office function, medical center operations and occupation health services, and other minor operations. The company was founded on September 25, 1934 and is headquartered in Sydney, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date
Date | Announcements |
---|---|
September 25, 2023 | Notification of cessation of securities - SHL |
September 25, 2023 | Application for quotation of securities - SHL |
September 25, 2023 | Application for quotation of securities - SHL |
September 25, 2023 | Acquisition of Synlab Suisse, Switzerland |
September 25, 2023 | Application for quotation of securities - SHL |
September 25, 2023 | Application for quotation of securities - SHL |
September 25, 2023 | Notification regarding unquoted securities - SHL |
September 25, 2023 | Acquisition of Medical Laboratories Duesseldorf Germany |
September 25, 2023 | Application for quotation of securities - SHL |
September 25, 2023 | Application for quotation of securities - SHL |
September 25, 2023 | Acquisition of Diagnosticum Laboratory Group Germany |
September 25, 2023 | Notification of cessation of securities - SHL |
September 25, 2023 | Application for quotation of securities - SHL |
September 25, 2023 | Change of Director's Interest Notice |
September 25, 2023 | Change of Director's Interest Notice |
September 25, 2023 | Notification of cessation of securities - SHL |
September 25, 2023 | Update - Notification of buy-back - SHL |
September 25, 2023 | Notification regarding unquoted securities - SHL |
September 25, 2023 | Application for quotation of securities - SHL |
September 25, 2023 | Application for quotation of securities - SHL |
Load More
Load Less
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
EPS (Basic) | $ |
|
|
|
|
6.32 | 6.32 | 6.32 |
|
|
|
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Date | keys |
---|---|
08 March 2023 | Update on Indonesian subsidiary PT Bank Commonwealth Update on Indonesian subsidiary PT Bank Commonwealth |
09 March 2023 | ASB 2023 Half Year Financial Results Media Release |
RVN · NASDAQ
Rivian,Inc
AUD $60.14
-3.56 (-1.581%)
RVN · NASDAQ
Rivian,Inc
AUD $60.14
-3.56 (-1.581%)
RVN · NASDAQ
Rivian,Inc
AUD $60.14
-3.56 (-1.581%)
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.